VARIABILITY OF BETA-BLOCKER PHARMACOKINETICS IN YOUNG VOLUNTEERS

被引:39
作者
JACK, DB
QUARTERMAN, CP
ZAMAN, R
KENDALL, MJ
机构
关键词
D O I
10.1007/BF01061375
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:37 / 42
页数:6
相关论文
共 19 条
[1]  
BARBER HE, 1981, BRIT J CLIN PHARMACO, V11, pP118
[2]   RELATION BETWEEN PLASMA CONCENTRATIONS AND CARDIOVASCULAR EFFECTS OF ORAL OXPRENOLOL IN MAN [J].
BRUNNER, L ;
IMHOF, P ;
JACK, D .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (01) :3-9
[3]   BIOAVAILABILITY OF CONVENTIONAL AND SLOW-RELEASE OXPRENOLOL IN FASTED AND NON-FASTED INDIVIDUALS [J].
DAWES, CP ;
KENDALL, MJ ;
WELLING, PG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (03) :299-302
[4]  
EMERSON TR, 1981, CURR THER RES CLIN E, V29, P693
[5]   PROPRANOLOL DYNAMICS IN THYROTOXICOSIS [J].
FEELY, J ;
STEVENSON, IH ;
CROOKS, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (01) :40-44
[6]   THE PHARMACOKINETICS OF ACEBUTOLOL IN MAN, FOLLOWING THE ORAL-ADMINISTRATION OF ACEBUTOLOL HCL AS A SINGLE DOSE (400 MG), AND DURING AND AFTER REPEATED ORAL DOSING (400 MG, BD) [J].
GULAID, AA ;
JAMES, IM ;
KAYE, CM ;
LEWELLEN, ORW ;
ROBERTS, E ;
SANKEY, M ;
SMITH, J ;
TEMPLETON, R ;
THOMAS, RJ .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1981, 2 (02) :103-114
[7]   INFLUENCE OF CIMETIDINE ON PHARMACOKINETICS OF PROPRANOLOL [J].
HEAGERTY, AM ;
DONOVAN, MA ;
CASTLEDEN, CM ;
POHL, JF ;
PATEL, L ;
HEDGES, A .
BRITISH MEDICAL JOURNAL, 1981, 282 (6280) :1917-1919
[8]   THE EFFECT OF IMPAIRED RENAL-FUNCTION ON THE PLASMA-CONCENTRATION AND URINARY-EXCRETION OF METOPROLOL METABOLITES [J].
HOFFMANN, KJ ;
REGARDH, CG ;
AURELL, M ;
ERVIK, M ;
JORDO, L .
CLINICAL PHARMACOKINETICS, 1980, 5 (02) :181-191
[9]   DETERMINATION OF LOW-LEVELS OF OXPRENOLOL IN BLOOD OR PLASMA BY GAS-LIQUID-CHROMATOGRAPHY [J].
JACK, DB ;
RIESS, W .
JOURNAL OF CHROMATOGRAPHY, 1974, 88 (01) :173-176
[10]  
KENDALL M J, 1977, European Journal of Drug Metabolism and Pharmacokinetics, V2, P73